Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 May 1;5(5):710-714.
doi: 10.1001/jamaoncol.2019.0038.

Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

Kyuwan Lee  1 , Debu Tripathy  2 , Wendy Demark-Wahnefried  3 , Kerry S Courneya  4 , Nathalie Sami  1 , Leslie Bernstein  5 , Darcy Spicer  6 , Thomas A Buchanan  7 , Joanne E Mortimer  8 , Christina M Dieli-Conwright  1   6
Affiliations
Randomized Controlled Trial

Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer: A Randomized Clinical Trial

Kyuwan Lee et al. JAMA Oncol. .

Abstract

Importance: The Framingham Risk Score (FRS) is a valid method for predicting the 10-year risk of developing cardiovascular disease. Higher FRS is reported in patients with early-stage breast cancer who are overweight than in healthy, age-matched women, but whether exercise reduces FRS in this patient population is unclear.

Objective: To examine the effects of a 16-week aerobic and resistance exercise intervention on the FRS in women with early-stage breast cancer and with overweight condition or obesity.

Design, setting, and participants: This single-center, prospective randomized clinical trial included 100 women with stage I to III breast cancer who were sedentary, with overweight condition or obesity (body mass index of ≥25.0 or body fat of ≥30%), and completed cancer treatment within 6 months prior to enrollment. Participants were randomized to either the usual care or exercise group. Differences in mean changes for outcomes were evaluated using mixed-model repeated-measures analyses. Data were collected from August 1, 2012, through July 1, 2017. Data analysis, which followed the intention-to-treat approach, was performed from May 24 to October 2, 2018.

Interventions: The exercise group underwent supervised aerobic and resistance exercise sessions thrice weekly for 16 weeks.

Main outcomes and measures: The FRS was calculated for each participant using preset points for each of the 6 FRS categories: age, systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, diabetes presence, and smoking status.

Results: In total, 100 women were randomized to either the exercise group (n = 50) or usual care group (n = 50). Of these women, 55 (55%) were of Hispanic white race/ethnicity and the mean (SD) age was 53.5 (10.4) years. The mean (SD) total FRS scores postintervention were 2.0 (1.5) in the exercise group and 13.0 (3.0) in the usual care group. The postintervention FRS was significantly reduced in the exercise group compared with the usual care group (mean, -9.5; 95% CI, -13.0 to -6.0), which corresponds to an 11% (95% CI, -15.0 to -5.0) decrease on the FRS-predicted 10-year risk of developing cardiovascular disease.

Conclusions and relevance: A 16-week supervised aerobic and resistance exercise intervention appeared to reduce the FRS-predicted 10-year risk of cardiovascular disease in women with early-stage breast cancer with overweight condition or obesity.

Clinical trial registration: ClinicalTrials.gov identifier: NCT01140282.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr. Mortimer reported receiving personal fees from Puma outside of the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Patient Flow Diagram
BMI indicates body mass index; EXE, exercise; UC, usual care.
See this image and copyright information in PMC

References

    1. Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology. 2016;27(1):6-13. doi:10.1097/EDE.0000000000000394 - DOI - PMC - PubMed
    1. Goh LG, Welborn TA, Dhaliwal SS. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study. BMC Womens Health. 2014;14:118. doi:10.1186/1472-6874-14-118 - DOI - PMC - PubMed
    1. Barroso LC, Muro EC, Herrera ND, Ochoa GF, Hueros JI, Buitrago F. Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study. Scand J Prim Health Care. 2010;28(4):242-248. doi:10.3109/02813432.2010.518407 - DOI - PMC - PubMed
    1. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847. doi:10.1161/01.CIR.97.18.1837 - DOI - PubMed
    1. Thomas GA, Alvarez-Reeves M, Lu L, Yu H, Irwin ML. Effect of exercise on metabolic syndrome variables in breast cancer survivors. Int J Endocrinol. 2013;2013:168797. doi:10.1155/2013/168797 - DOI - PMC - PubMed

Publication types

Associated data